CRP and cancer: When patients with an underlying diagnosis of cancer were excluded from the analysis, combined biochemical markers of low-grade inflammation (GPS), serum CRP >10mg/L and low serum albumin concentrations <35 g/L remained independently associated with higher 6-month mortality.